ALSTOM SA: Alstom awarded 25 additional Coradia Continental

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
85
ALSTOM SA: Alstom awarded 25 additional Coradia Continental regional trains by DB Regio AG

                                                                                                       

                                                                                                                      An order worth around €150 million Alstom awarded 25 additional Coradia Continental regional trains by DB Regio AG 3 May 2017 - Alstom and DB Regio AG have signed a new contract for 25 Coradia Continental electric multiple units for the region of Saarland and Rhineland-Palatinate. This order is part of a frame contract concluded between the DB Regio AG and Alstom in 2012 for the delivery of up to 400 Coradia Continental trains. This order is worth around €150 million. The trains will be manufactured in Salzgitter (Germany).

This order has been initiated by the contract won by DB Regio AG for the operation of the Saar RB electrical network batch 1 on the routes Schweich - Trier Hbf - Saarbrücken Hbf - Kaiserslautern Hbf (from December 2019) and Trier Hafenstraße - Konz - Saarburg (from December 2020). Purchasers of the these transport operations are the Ministry for Economy, Labour, Energy and Transport in Saarland as well as the administration unions SPNV-North and ZSPNV-South associations in Rhineland-Palatinate.

"After 53 trains ordered last month by Deutsche Bahn, the total number of Coradia Continental sold within the current frame contract exceeds 100 units, proving the satisfaction of our customer for this train. Coradia Continental is a well-proven train for its regional operations, with a track record of 35 million kilometres per year performed by the total fleet in service and an availability rate of 99% per customer fleet ", says Didier Pfleger, Vice President Alstom Germany and Austria.

Running at a maximum speed of 160 km/h, the 25 four-car Coradia Continental trains are fitted with up to 200 seats. The trains are characterized by excellent acceleration properties, as well as a particularly smooth and quiet running.

Coradia Continental meets the latest European standards in terms of fire protection, accessibility and emission values. For the vehicle specification in the tender the public transport authorities placed special attention on passenger comfort: multi-purpose areas provide sufficient space for wheelchairs, bicycles and prams. The traction equipment is located on the roof to allow for more spacious interior. Access at platform height, movable steps and continuous low-floor areas allow barrier-free travel. In accordance with the contractual arrangements the vehicles are equipped with repeaters for an improved mobile communication, as well as with sockets, video cameras and real-time passenger information system displaying current train connection data.

Coradia Continental belongs to Alstom's Coradia range of modular trains that benefit from a know-how of more than 30 years and from well-proven technical solutions. More than 2,400 Coradia trains have been sold so far, and 1,900 are presently circulating in Denmark, France, Germany, Italy, Luxembourg, the Netherlands, Portugal, Spain, Sweden and Canada.

About Alstom As a promoter of sustainable mobility, Alstom develops and markets systems, equipment and services for the railway sector. Alstom manages the widest range of solutions in the market - from high-speed trains to metros and tramways - customised services (maintenance, modernisation,.) and infrastructure and signalling solutions. Alstom is a world leader in integrated railway systems. It recorded sales of €6.9 billion and booked €10.6 billion of orders in the 2015/16 fiscal year. Headquartered in France, Alstom is present in over 60 countries and employs 31,000 people today. www.alstom.com

Press contacts Justine Rohée - Tel. + 33 1 57 06 18 81 justine.rohee@alstom.com

Christopher English - Tel. + 33 1 57 06 36 90 christopher.a.english@alstom.com

Tanja Kampa - Tel. + 49 5341- 9007690 tanja.kampa@alstom.com

Investor relations Selma Bekhechi - Tel. + 33 1 57 06 95 39 Selma.bekhechi@alstom.com

Julien Minot - Tel. + 33 1 57 06 64 84 Julien.minot@alstom.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...476daa9b6f

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading